Reckitt Benckiser shares sink on cut growth projections

Reckitt Lysol

Investors lost faith with Reckitt Benckiser’s recovery this week to send shares plummeting at the Durex and Strepsils owner.

The FTSE 100 group trimmed its growth forecasts for 2026 after being hit with unexpected manufacturing problems for its Lysol disinfectant brand in North America and weakness in the Chinese supplements business.

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW